Go Pro

Research Frontiers (REFR) Financials

Research Frontiers logo
$0.51 +0.00 (+0.18%)
Closing price 04:00 PM Eastern
Extended Trading
$0.53 +0.02 (+3.52%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Research Frontiers

Annual Income Statements for Research Frontiers

This table shows Research Frontiers' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-4.28 -4.24 -2.41 -2.69 -3.81 -2.34 -1.85 -2.67 -1.91 -1.31 -2.05
Consolidated Net Income / (Loss)
-4.28 -4.24 -2.41 -2.69 -3.81 -2.34 -1.85 -2.67 -1.91 -1.31 -2.05
Net Income / (Loss) Continuing Operations
-4.28 -4.24 -2.41 -2.69 -3.76 -2.34 -1.85 -2.67 -1.91 -1.31 -2.05
Total Pre-Tax Income
-4.28 -4.24 -2.41 -2.69 -3.76 -2.34 -1.85 -2.67 -1.91 -1.31 -2.05
Total Operating Income
-4.32 -4.27 -2.42 -2.42 -3.15 -2.58 -1.84 -2.63 -2.03 -1.44 -2.13
Total Gross Profit
2.01 1.24 1.51 1.49 1.56 0.83 1.26 0.54 0.91 1.34 1.12
Total Revenue
2.01 1.24 1.51 1.49 1.56 0.83 1.26 0.54 0.91 1.34 1.12
Operating Revenue
2.01 1.24 1.51 1.49 1.56 0.83 1.26 0.54 0.91 1.34 1.12
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
6.33 5.50 3.93 3.91 4.71 3.41 3.10 3.16 2.94 2.78 3.25
Selling, General & Admin Expense
4.74 4.09 3.13 3.04 3.68 2.78 2.52 2.56 2.36 2.21 2.64
Research & Development Expense
1.59 1.42 0.80 0.86 1.04 0.63 0.58 0.61 0.58 0.57 0.61
Total Other Income / (Expense), net
0.04 0.03 0.00 -0.27 -0.61 0.24 -0.01 -0.04 0.12 0.13 0.09
Interest & Investment Income
0.04 0.03 0.00 0.01 0.04 0.03 - -0.04 0.12 0.10 0.04
Other Income / (Expense), net
- 0.00 0.00 -0.28 -0.65 0.20 -0.01 - 0.00 0.04 0.05
Basic Earnings per Share
($0.18) ($0.18) ($0.10) ($0.10) ($0.13) ($0.07) ($0.06) ($0.08) ($0.06) ($0.04) ($0.06)
Weighted Average Basic Shares Outstanding
24.01M 24.04M 24.04M 25.96M 30.01M 31.49M 31.65M 32.07M 33.45M 33.52M 33.65M
Diluted Earnings per Share
($0.18) ($0.18) ($0.10) ($0.10) ($0.13) ($0.07) - ($0.08) ($0.06) ($0.04) ($0.06)
Weighted Average Diluted Shares Outstanding
24.01M 24.04M 24.04M 25.96M 30.01M 31.49M 31.65M 32.07M 33.45M 33.52M 33.65M
Weighted Average Basic & Diluted Shares Outstanding
24.01M 24.04M 24.04M 25.96M 30.01M 31.49M 31.65M 33.51M 33.51M 33.65M 34.65M

Quarterly Income Statements for Research Frontiers

This table shows Research Frontiers' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-0.47 -0.48 -0.44 -0.09 -0.17 -0.61 -0.18 -0.80 -0.30 -0.77 -0.53
Consolidated Net Income / (Loss)
-0.47 -0.48 -0.44 -0.09 -0.17 -0.61 -0.18 -0.80 -0.30 -0.77 -0.53
Net Income / (Loss) Continuing Operations
-0.47 -0.48 -0.44 -0.09 -0.17 -0.61 -0.18 -0.80 -0.30 -0.77 -0.53
Total Pre-Tax Income
-0.47 -0.48 -0.44 -0.09 -0.17 -0.61 -0.18 -0.80 -0.30 -0.77 -0.53
Total Operating Income
-0.51 -0.51 -0.47 -0.12 -0.23 -0.62 -0.24 -0.82 -0.30 -0.77 -0.53
Total Gross Profit
0.16 0.31 0.31 0.49 0.35 0.18 0.56 0.13 0.36 0.07 0.14
Total Revenue
0.16 0.31 0.31 0.49 0.35 0.18 0.56 0.13 0.36 0.07 0.14
Operating Revenue
0.16 0.31 0.31 0.49 0.35 0.18 0.56 0.13 0.36 0.07 0.14
Total Cost of Revenue
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses
0.68 0.82 0.78 0.61 0.59 0.80 0.80 0.95 0.66 0.85 0.67
Selling, General & Admin Expense
0.54 0.66 0.63 0.48 0.45 0.64 0.64 0.78 0.52 0.71 0.52
Research & Development Expense
0.14 0.15 0.15 0.13 0.13 0.16 0.16 0.17 0.14 0.14 0.15
Total Other Income / (Expense), net
0.04 0.03 0.03 0.02 0.06 0.02 0.06 0.01 0.01 0.01 0.01
Interest & Investment Income
0.04 0.03 0.03 0.02 0.03 0.02 0.01 0.01 0.01 0.01 0.01
Other Income / (Expense), net
0.00 - 0.00 0.00 0.04 - 0.05 0.00 0.00 - 0.00
Basic Earnings per Share
($0.01) ($0.03) ($0.01) $0.00 $0.00 ($0.03) ($0.01) ($0.02) ($0.01) ($0.02) ($0.02)
Weighted Average Basic Shares Outstanding
33.51M 33.45M 33.51M 33.52M 33.52M 33.52M 33.65M 33.65M 33.65M 33.65M 34.16M
Diluted Earnings per Share
($0.01) ($0.03) ($0.01) $0.00 $0.00 ($0.03) ($0.01) ($0.02) ($0.01) ($0.02) ($0.02)
Weighted Average Diluted Shares Outstanding
33.51M 33.45M 33.51M 33.52M 33.52M 33.52M 33.65M 33.65M 33.65M 33.65M 34.16M
Weighted Average Basic & Diluted Shares Outstanding
33.51M 33.51M 33.52M 33.52M 33.52M 33.65M 33.65M 33.65M 33.65M 34.65M 34.87M

Annual Cash Flow Statements for Research Frontiers

This table details how cash moves in and out of Research Frontiers' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1.86 -4.02 0.05 1.23 3.62 -1.82 -4.50 3.96 -1.75 -0.48 -1.33
Net Cash From Operating Activities
-3.58 -4.01 -1.47 -2.07 -2.08 -2.25 -1.80 -2.18 -2.30 -0.79 -1.33
Net Cash From Continuing Operating Activities
-3.58 -4.01 -1.47 -2.07 -2.08 -2.25 -1.80 -2.18 -2.30 -0.79 -1.33
Net Income / (Loss) Continuing Operations
-4.28 -4.24 -2.41 -2.69 -3.81 -2.34 -1.85 -2.67 -1.91 -1.31 -2.05
Consolidated Net Income / (Loss)
-4.28 -4.24 -2.41 -2.69 -3.81 -2.34 -1.85 -2.67 -1.91 -1.31 -2.05
Depreciation Expense
0.14 0.19 0.18 0.18 0.20 0.07 0.03 0.03 0.03 0.03 0.01
Amortization Expense
- - - - - - 0.15 0.15 0.14 0.24 0.17
Non-Cash Adjustments To Reconcile Net Income
1.05 0.55 0.13 0.31 1.70 0.18 -0.15 0.25 -0.01 0.11 0.40
Changes in Operating Assets and Liabilities, net
-0.49 -0.51 0.63 0.12 -0.17 -0.16 0.02 0.06 -0.55 0.14 0.13
Net Cash From Investing Activities
1.18 -0.02 1.52 -0.01 -0.07 -0.05 -2.78 2.69 0.06 -0.00 -0.00
Net Cash From Continuing Investing Activities
1.18 -0.02 1.52 -0.01 -0.07 -0.05 -2.78 2.69 0.06 -0.00 -0.00
Purchase of Property, Plant & Equipment
-0.32 -0.01 -0.01 -0.01 -0.07 -0.06 -0.00 -0.00 -0.00 -0.00 -0.00
Net Cash From Financing Activities
0.55 0.00 0.00 3.31 5.77 0.49 0.09 3.45 0.48 0.31 0.00
Net Cash From Continuing Financing Activities
0.55 0.00 0.00 3.31 5.77 0.49 0.09 3.45 0.48 0.31 0.00
Issuance of Common Equity
- - - - - - 0.00 3.45 0.00 0.30 0.00
Other Financing Activities, net
0.55 0.00 0.00 3.31 5.77 0.28 0.09 0.00 0.48 0.01 0.00

Quarterly Cash Flow Statements for Research Frontiers

This table details how cash moves in and out of Research Frontiers' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-2.99 1.95 -0.38 -0.19 -0.26 0.35 -0.64 -0.08 -0.14 -0.47 0.62
Net Cash From Operating Activities
-0.52 -0.55 -0.39 -0.19 -0.26 0.05 -0.64 -0.08 -0.14 -0.47 -0.76
Net Cash From Continuing Operating Activities
-0.52 -0.55 -0.39 -0.19 -0.26 0.05 -0.64 -0.08 -0.14 -0.47 -0.76
Net Income / (Loss) Continuing Operations
-0.47 -0.48 -0.44 -0.09 -0.17 -0.61 -0.18 -0.80 -0.30 -0.77 -0.53
Consolidated Net Income / (Loss)
-0.47 -0.48 -0.44 -0.09 -0.17 -0.61 -0.18 -0.80 -0.30 -0.77 -0.53
Depreciation Expense
0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Amortization Expense
0.04 0.04 0.04 0.04 0.04 0.13 0.04 0.04 0.04 0.04 0.04
Non-Cash Adjustments To Reconcile Net Income
0.02 0.09 -0.05 -0.05 -0.03 0.25 -0.03 0.27 -0.03 0.20 -0.04
Changes in Operating Assets and Liabilities, net
-0.11 -0.21 0.06 -0.08 -0.10 0.27 -0.48 0.41 0.14 0.06 -0.24
Net Cash From Investing Activities
-2.47 2.50 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Net Cash From Continuing Investing Activities
-2.47 2.50 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Purchase of Property, Plant & Equipment
0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Net Cash From Financing Activities
- - 0.01 - - 0.30 0.00 - - - 1.38
Net Cash From Continuing Financing Activities
- - 0.01 - - 0.30 0.00 - - - 1.38
Other Financing Activities, net
- - 0.01 - - - - - - - 1.38

Annual Balance Sheets for Research Frontiers

This table presents Research Frontiers' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
9.54 5.27 2.88 4.06 8.26 6.20 4.55 5.37 3.85 4.04 2.25
Total Current Assets
8.67 4.59 2.36 3.71 7.31 5.43 3.95 4.92 3.58 2.75 1.14
Cash & Equivalents
5.71 1.69 1.74 2.97 6.59 4.77 0.27 4.23 2.48 1.99 0.66
Accounts Receivable
1.31 1.12 0.60 - - - - 0.59 1.00 0.66 0.41
Prepaid Expenses
0.13 0.26 0.03 0.05 0.06 0.06 0.09 0.10 0.10 0.09 0.07
Plant, Property, & Equipment, net
0.84 0.65 0.48 0.31 0.14 0.12 0.09 0.07 0.04 0.02 0.00
Total Noncurrent Assets
0.03 0.03 0.03 0.03 0.81 0.65 0.50 0.38 0.23 1.28 1.10
Other Noncurrent Operating Assets
0.03 0.03 0.03 0.03 0.81 0.65 0.50 0.38 0.23 1.28 1.10
Total Liabilities & Shareholders' Equity
9.54 5.27 2.88 4.06 8.26 6.20 4.55 5.37 3.85 4.04 2.25
Total Liabilities
0.47 0.37 0.31 0.96 1.20 0.87 0.76 0.57 0.33 1.44 1.32
Total Current Liabilities
0.47 0.37 0.31 0.46 0.39 0.23 0.30 0.30 0.28 0.27 0.30
Accounts Payable
0.05 0.03 0.06 0.13 0.17 0.03 0.07 0.07 0.05 0.09 0.13
Accrued Expenses
0.42 0.34 0.25 0.27 0.05 0.03 0.05 0.03 0.01 0.05 0.02
Other Current Liabilities
- - - 0.00 0.16 0.17 0.18 0.20 0.21 0.13 0.15
Total Noncurrent Liabilities
0.00 0.00 0.00 0.50 0.81 0.65 0.46 0.27 0.06 1.17 1.02
Other Noncurrent Operating Liabilities
- - 0.00 0.50 0.81 0.65 0.46 0.27 0.06 1.17 1.02
Total Equity & Noncontrolling Interests
9.08 4.90 2.57 3.10 7.06 5.33 3.78 4.80 3.52 2.60 0.93
Total Preferred & Common Equity
9.08 4.90 2.57 3.10 7.06 5.33 3.78 4.80 3.52 2.60 0.93
Total Common Equity
9.08 4.90 2.57 3.10 7.06 5.33 3.78 4.80 3.52 2.60 0.93
Common Stock
111 112 112 115 123 123 123 127 128 128 129
Retained Earnings
-102 -107 -109 -112 -115 -118 -120 -122 -124 -126 -128

Quarterly Balance Sheets for Research Frontiers

This table presents Research Frontiers' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
4.23 3.52 3.38 3.00 3.77 3.17 2.77 3.08
Total Current Assets
3.91 3.29 3.19 2.85 2.52 1.97 1.61 2.02
Cash & Equivalents
0.52 2.09 1.91 1.65 1.35 1.27 1.13 1.28
Accounts Receivable
0.72 0.96 1.08 1.05 0.97 0.54 0.37 0.54
Prepaid Expenses
0.16 0.24 0.20 0.15 0.20 0.16 0.11 0.19
Plant, Property, & Equipment, net
0.05 0.03 0.03 0.02 0.01 0.01 0.01 0.00
Total Noncurrent Assets
0.27 0.20 0.16 0.13 1.24 1.19 1.15 1.06
Other Noncurrent Operating Assets
0.27 0.20 0.16 0.13 1.24 1.19 1.15 1.06
Total Liabilities & Shareholders' Equity
4.23 3.52 3.38 3.00 3.77 3.17 2.77 3.08
Total Liabilities
0.37 0.44 0.39 0.18 1.34 1.37 1.27 1.30
Total Current Liabilities
0.26 0.44 0.39 0.18 0.21 0.28 0.21 0.32
Accounts Payable
0.03 0.17 0.06 0.03 0.01 0.02 0.03 0.10
Accrued Expenses
0.02 0.05 0.04 0.03 0.06 0.05 0.04 0.07
Other Current Liabilities
0.21 0.22 0.16 0.11 0.13 0.14 0.14 0.15
Total Noncurrent Liabilities
0.11 0.00 0.00 0.00 1.13 1.09 1.06 0.98
Other Noncurrent Operating Liabilities
0.11 0.00 0.00 0.00 1.13 1.09 1.06 0.98
Total Equity & Noncontrolling Interests
3.85 3.08 2.99 2.82 2.43 1.80 1.50 1.78
Total Preferred & Common Equity
3.85 3.08 2.99 2.82 2.43 1.80 1.50 1.78
Total Common Equity
3.85 3.08 2.99 2.82 2.43 1.80 1.50 1.78
Common Stock
128 128 128 128 128 128 128 130
Retained Earnings
-124 -125 -125 -125 -126 -127 -127 -128

Annual Metrics And Ratios for Research Frontiers

This table displays calculated financial ratios and metrics derived from Research Frontiers' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
24,043,846.00 24,043,846.00 24,043,846.00 27,662,211.00 31,090,291.00 31,575,786.00 31,650,396.00 33,150,396.00 33,509,287.00 33,517,787.00 33,648,221.00
DEI Adjusted Shares Outstanding
24,043,846.00 24,043,846.00 24,043,846.00 27,662,211.00 31,090,291.00 31,575,786.00 31,650,396.00 33,150,396.00 33,509,287.00 33,517,787.00 33,648,221.00
DEI Earnings Per Adjusted Shares Outstanding
-0.18 -0.18 -0.10 -0.10 -0.12 -0.07 -0.06 -0.08 -0.06 -0.04 -0.06
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.56% -38.43% 22.08% -1.35% 5.06% -47.03% 52.46% -57.27% 68.54% 46.83% -16.04%
EBITDA Growth
5.30% 2.48% 45.02% -12.14% -43.37% 35.99% 27.66% -46.72% 24.03% 38.58% -66.04%
EBIT Growth
2.83% 1.28% 43.33% -11.48% -40.99% 37.51% 22.27% -42.18% 22.54% 30.82% -48.20%
NOPAT Growth
2.83% 1.28% 43.33% 0.02% -30.23% 18.16% 28.66% -42.76% 22.54% 29.09% -47.87%
Net Income Growth
3.03% 0.97% 43.05% -11.28% -41.80% 38.54% 21.13% -44.57% 28.51% 31.28% -55.99%
EPS Growth
5.26% 0.00% 44.44% 0.00% -30.00% 46.15% 0.00% 0.00% 25.00% 33.33% -50.00%
Operating Cash Flow Growth
-7.73% -11.86% 63.29% -40.84% -0.56% -8.16% 19.91% -20.98% -5.15% 65.63% -68.50%
Free Cash Flow Firm Growth
8.84% 16.05% 70.56% -19.31% -155.57% 25.38% 21.25% -10.25% -15.47% 69.58% -99.36%
Invested Capital Growth
22.70% -8.63% -50.92% -84.32% 256.83% 19.42% 36.90% -25.42% 84.08% -41.43% -55.86%
Revenue Q/Q Growth
-3.05% -7.55% 0.11% 6.54% 0.69% -23.25% 6.94% -13.27% 25.07% -9.12% -8.64%
EBITDA Q/Q Growth
-8.19% 9.64% 24.23% -11.25% -19.24% 17.69% 13.38% -2.12% 14.41% 0.90% -14.42%
EBIT Q/Q Growth
-8.97% 9.28% 22.95% -10.49% -18.19% 18.58% 5.47% -1.97% 13.40% -6.33% -7.71%
NOPAT Q/Q Growth
-8.97% 9.28% 22.95% 0.90% -22.41% 11.65% 5.85% -1.97% 13.40% -8.99% -7.53%
Net Income Q/Q Growth
-8.98% 9.20% 22.90% 1.26% -19.54% 13.77% 5.15% -1.24% 14.95% -10.82% -8.35%
EPS Q/Q Growth
-12.50% 10.00% 23.08% 9.09% -18.18% 12.50% 0.00% 0.00% 0.00% 0.00% 14.29%
Operating Cash Flow Q/Q Growth
-2.77% -16.51% 36.37% 0.76% 0.45% -9.13% 27.28% -40.64% 0.80% 43.03% -62.86%
Free Cash Flow Firm Q/Q Growth
15.05% -8.38% 42.79% 6.86% -11.24% -13.18% 34.86% -61.41% -0.48% 54.61% -97.82%
Invested Capital Q/Q Growth
-22.84% -1.36% -14.60% -60.54% -42.75% 25.32% -44.41% -2.73% 25.77% -48.07% -27.04%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-208.37% -330.03% -148.63% -168.96% -230.56% -278.62% -132.21% -453.96% -204.61% -85.60% -169.29%
Operating Margin
-215.35% -345.28% -160.27% -162.44% -201.36% -311.11% -145.59% -486.42% -223.54% -107.96% -190.16%
EBIT Margin
-215.35% -345.28% -160.27% -181.12% -243.05% -286.72% -146.18% -486.42% -223.54% -105.33% -185.94%
Profit (Net Income) Margin
-213.20% -342.89% -159.96% -180.44% -243.54% -282.56% -146.18% -494.61% -209.80% -98.19% -182.44%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 101.35% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
99.00% 99.31% 99.80% 99.62% 98.87% 98.55% 100.00% 101.68% 93.86% 93.22% 98.12%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-180.28% -168.80% -134.39% -352.81% -741.99% -354.30% -196.04% -277.41% -177.06% -122.20% -339.41%
ROIC Less NNEP Spread (ROIC-NNEP)
-166.19% -144.84% -105.29% -310.60% -708.43% -344.85% -181.70% -254.49% -162.60% -108.68% -297.80%
Return on Net Nonoperating Assets (RNNOA)
139.82% 108.17% 69.79% 258.01% 666.98% 316.49% 155.51% 215.20% 131.16% 79.36% 223.77%
Return on Equity (ROE)
-40.46% -60.63% -64.61% -94.80% -75.01% -37.81% -40.53% -62.22% -45.90% -42.84% -115.64%
Cash Return on Invested Capital (CROIC)
-200.66% -159.78% -66.09% -207.03% -854.43% -372.00% -227.20% -248.29% -236.25% -69.94% -261.91%
Operating Return on Assets (OROA)
-39.11% -57.60% -59.31% -77.71% -61.74% -32.86% -34.37% -52.97% -44.12% -35.66% -66.28%
Return on Assets (ROA)
-38.72% -57.21% -59.20% -77.41% -61.86% -32.39% -34.37% -53.86% -41.41% -33.24% -65.03%
Return on Common Equity (ROCE)
-40.46% -60.63% -64.61% -94.80% -75.01% -37.81% -40.53% -62.22% -45.90% -42.84% -115.64%
Return on Equity Simple (ROE_SIMPLE)
-47.16% -86.41% -94.02% -86.66% -53.98% -43.94% -48.79% -55.65% -54.25% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.03 -2.99 -1.69 -1.69 -2.20 -1.80 -1.29 -1.84 -1.42 -1.01 -1.49
NOPAT Margin
-150.75% -241.69% -112.19% -113.71% -140.95% -217.78% -101.91% -340.49% -156.48% -75.57% -133.11%
Net Nonoperating Expense Percent (NNEP)
-14.09% -23.96% -29.11% -42.21% -33.56% -9.44% -14.34% -22.93% -14.46% -13.52% -41.61%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -40.46% -38.76% -159.86%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
236.22% 330.59% 207.28% 204.45% 235.15% 335.27% 199.67% 473.55% 259.42% 165.28% 235.87%
R&D to Revenue
79.13% 114.69% 52.99% 58.00% 66.22% 75.84% 45.92% 112.87% 64.12% 42.68% 54.29%
Operating Expenses to Revenue
315.35% 445.28% 260.27% 262.44% 301.36% 411.11% 245.59% 586.42% 323.54% 207.96% 290.16%
Earnings before Interest and Taxes (EBIT)
-4.32 -4.27 -2.42 -2.70 -3.80 -2.38 -1.85 -2.63 -2.03 -1.41 -2.08
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.18 -4.08 -2.24 -2.52 -3.61 -2.31 -1.67 -2.45 -1.86 -1.14 -1.90
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
13.80 8.92 9.74 13.92 13.26 16.66 14.39 13.20 9.62 22.01 47.21
Price to Tangible Book Value (P/TBV)
13.80 8.92 9.74 13.92 13.26 16.66 14.39 13.20 9.62 22.01 47.21
Price to Revenue (P/Rev)
62.40 35.40 16.57 28.99 59.83 107.10 43.10 117.32 37.21 42.92 39.31
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
63.82 23.99 28.05 308.93 187.42 151.46 67.75 104.40 30.11 90.67 161.20
Enterprise Value to Revenue (EV/Rev)
58.80 32.80 15.42 26.99 55.62 101.34 40.71 109.48 34.49 41.42 38.72
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.84 -0.75 -0.66 -0.83 -0.94 -0.92 -0.86 -0.85 -0.81 -0.73 -0.75
Leverage Ratio
1.04 1.06 1.09 1.22 1.21 1.17 1.18 1.16 1.11 1.29 1.78
Compound Leverage Factor
1.03 1.05 1.09 1.22 1.20 1.15 1.18 1.17 1.04 1.20 1.74
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
145.25 41.32 -6.57 -12.39 26.88 34.30 5.90 34.30 15.36 -19.64 -61.39
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
18.53 12.43 7.54 8.11 18.86 24.01 13.26 16.30 12.89 10.21 3.84
Quick Ratio
18.24 11.73 7.44 6.49 17.01 21.11 10.15 15.97 12.54 9.86 3.60
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3.37 -2.83 -0.83 -0.99 -2.54 -1.89 -1.49 -1.64 -1.90 -0.58 -1.15
Operating Cash Flow to CapEx
-1,132.51% -70,086.49% -22,454.42% -17,757.52% -3,190.34% -4,264.60% -167,529.53% -171,734.46% -147,307.51% -48,602.53% -183,080.03%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.18 0.17 0.37 0.43 0.25 0.11 0.24 0.11 0.20 0.34 0.36
Accounts Receivable Turnover
1.61 1.02 1.76 0.00 0.00 0.00 0.00 0.00 1.14 1.61 2.10
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
2.68 1.66 2.66 3.74 6.88 6.29 11.76 6.82 17.33 48.88 121.58
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
226.36 359.04 207.35 0.00 0.00 0.00 0.00 0.00 319.62 227.06 173.65
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
226.36 359.04 207.35 0.00 0.00 0.00 0.00 0.00 319.62 227.06 173.65
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1.85 1.69 0.83 0.13 0.46 0.55 0.76 0.57 1.04 0.61 0.27
Invested Capital Turnover
1.20 0.70 1.20 3.10 5.26 1.63 1.92 0.81 1.13 1.62 2.55
Increase / (Decrease) in Invested Capital
0.34 -0.16 -0.86 -0.70 0.33 0.09 0.20 -0.19 0.48 -0.43 -0.34
Enterprise Value (EV)
118 41 23 40 87 84 51 59 31 55 43
Market Capitalization
125 44 25 43 94 89 54 63 34 57 44
Book Value per Share
$0.38 $0.20 $0.11 $0.11 $0.23 $0.17 $0.12 $0.14 $0.11 $0.08 $0.03
Tangible Book Value per Share
$0.38 $0.20 $0.11 $0.11 $0.23 $0.17 $0.12 $0.14 $0.11 $0.08 $0.03
Total Capital
9.08 4.90 2.57 3.10 7.06 5.33 3.78 4.80 3.52 2.60 0.93
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-7.23 -3.21 -1.74 -2.97 -6.59 -4.77 -3.03 -4.23 -2.48 -1.99 -0.66
Capital Expenditures (CapEx)
0.32 0.01 0.01 0.01 0.07 0.05 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.98 1.00 0.31 0.28 0.33 0.43 0.63 0.39 0.82 0.48 0.18
Debt-free Net Working Capital (DFNWC)
8.21 4.22 2.05 3.25 6.92 5.20 3.65 4.62 3.30 2.48 0.85
Net Working Capital (NWC)
8.21 4.22 2.05 3.25 6.92 5.20 3.65 4.62 3.30 2.48 0.85
Net Nonoperating Expense (NNE)
1.25 1.25 0.72 0.99 1.60 0.54 0.56 0.83 0.49 0.30 0.55
Net Nonoperating Obligations (NNO)
-7.23 -3.21 -1.74 -2.97 -6.59 -4.77 -3.03 -4.23 -2.48 -1.99 -0.66
Total Depreciation and Amortization (D&A)
0.14 0.19 0.18 0.18 0.20 0.07 0.18 0.18 0.17 0.26 0.19
Debt-free, Cash-free Net Working Capital to Revenue
48.81% 81.29% 20.77% 19.13% 20.94% 51.75% 49.61% 72.03% 90.45% 36.14% 16.21%
Debt-free Net Working Capital to Revenue
408.77% 341.37% 135.93% 218.60% 442.41% 627.85% 289.12% 855.98% 362.66% 185.46% 75.46%
Net Working Capital to Revenue
408.77% 341.37% 135.93% 218.60% 442.41% 627.85% 289.12% 855.98% 362.66% 185.46% 75.46%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.18) ($0.18) ($0.10) ($0.10) ($0.13) ($0.07) ($0.06) ($0.08) ($0.06) ($0.04) ($0.06)
Adjusted Weighted Average Basic Shares Outstanding
24.04M 24.04M 24.04M 28.67M 31.41M 31.65M 31.65M 32.07M 33.45M 33.52M 33.65M
Adjusted Diluted Earnings per Share
($0.18) ($0.18) ($0.10) ($0.10) ($0.13) ($0.07) ($0.06) $0.00 ($0.06) ($0.04) ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding
24.04M 24.04M 24.04M 28.67M 31.41M 31.65M 31.65M 33.51M 33.45M 33.52M 33.65M
Adjusted Basic & Diluted Earnings per Share
($0.18) ($0.18) ($0.10) ($0.10) ($0.13) ($0.07) ($0.06) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
24.01M 24.04M 24.04M 25.96M 30.01M 31.49M 31.65M 33.51M 33.51M 33.65M 34.65M
Normalized Net Operating Profit after Tax (NOPAT)
-3.03 -2.99 -1.69 -1.69 -2.20 -1.80 -1.29 -1.84 -1.42 -1.01 -1.49
Normalized NOPAT Margin
-150.75% -241.69% -112.19% -113.71% -140.95% -217.78% -101.91% -340.49% -156.48% -75.57% -133.11%
Pre Tax Income Margin
-213.20% -342.89% -159.96% -180.44% -240.30% -282.56% -146.18% -494.61% -209.80% -98.19% -182.44%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Research Frontiers

This table displays calculated financial ratios and metrics derived from Research Frontiers' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
33,509,287.00 33,509,287.00 33,509,287.00 33,517,787.00 33,517,787.00 33,517,787.00 33,648,221.00 33,648,221.00 33,648,221.00 33,648,221.00 34,648,221.00
DEI Adjusted Shares Outstanding
33,509,287.00 33,509,287.00 33,509,287.00 33,517,787.00 33,517,787.00 33,517,787.00 33,648,221.00 33,648,221.00 33,648,221.00 33,648,221.00 34,648,221.00
DEI Earnings Per Adjusted Shares Outstanding
-0.01 -0.01 -0.01 0.00 -0.01 -0.02 -0.01 -0.02 -0.01 -0.02 -0.02
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.11% 140.36% 26.27% 164.59% 115.91% -42.94% 78.63% -73.47% 1.42% -59.52% -75.65%
EBITDA Growth
-6.54% 40.38% 3.94% 84.67% 67.28% -5.35% 65.88% -939.85% -66.79% -49.07% -233.40%
EBIT Growth
-5.68% 38.37% 3.91% 77.89% 61.75% -23.53% 59.08% -601.87% -54.64% -23.91% -175.94%
NOPAT Growth
-5.68% 38.37% 3.91% 77.89% 54.90% -23.53% 49.00% -601.87% -31.18% -23.91% -121.40%
Net Income Growth
2.39% 41.15% 4.33% 80.95% 64.67% -26.68% 59.85% -754.93% -78.94% -25.93% -195.67%
EPS Growth
50.00% 0.00% 0.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00% 33.33% -100.00%
Operating Cash Flow Growth
2.31% 3.25% 34.50% 70.14% 50.72% 108.58% -63.96% 58.03% 44.36% -1,089.69% -18.50%
Free Cash Flow Firm Growth
-236.87% -117.65% -93.50% 44.69% 16.04% 99.35% 60.81% 96.91% 216.55% -3,632.83% 179.06%
Invested Capital Growth
42.35% 84.08% 46.02% 34.15% 41.85% -41.43% 8.43% -51.65% -68.58% -55.86% -53.07%
Revenue Q/Q Growth
-11.29% 90.22% 0.37% 56.23% -27.61% -49.73% 214.21% -76.79% 176.70% -79.93% 89.01%
EBITDA Q/Q Growth
2.25% 1.79% 7.61% 82.72% -108.66% -216.21% 70.07% -426.63% 66.53% -182.62% 33.07%
EBIT Q/Q Growth
2.18% 1.64% 7.05% 75.28% -69.25% -217.62% 69.21% -324.05% 62.71% -154.50% 31.43%
NOPAT Q/Q Growth
2.18% 1.64% 7.05% 75.28% -99.51% -169.43% 61.62% -240.23% 62.71% -154.50% 31.43%
Net Income Q/Q Growth
4.35% -1.64% 7.77% 78.76% -77.42% -264.44% 70.77% -352.38% 62.86% -156.46% 31.38%
EPS Q/Q Growth
0.00% -200.00% 66.67% 100.00% 0.00% 0.00% 66.67% -100.00% 50.00% -100.00% 0.00%
Operating Cash Flow Q/Q Growth
16.36% -4.84% 28.72% 52.23% -38.04% 118.25% -1,462.09% 87.77% -82.98% -224.67% -63.09%
Free Cash Flow Firm Q/Q Growth
6.11% -36.87% 22.74% 44.29% -42.51% 98.94% -4,573.20% 95.60% 5,467.37% -133.83% 198.97%
Invested Capital Q/Q Growth
2.58% 25.77% -4.94% 9.38% 8.47% -48.07% 76.00% -51.23% -29.52% -27.04% 87.12%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-287.08% -148.22% -136.44% -15.09% -43.50% -273.66% -26.06% -591.47% -71.54% -1,007.65% -356.82%
Operating Margin
-313.02% -161.86% -149.90% -23.72% -65.38% -350.42% -42.80% -627.47% -84.56% -1,072.52% -389.10%
EBIT Margin
-313.02% -161.86% -149.90% -23.72% -55.46% -350.42% -34.34% -627.47% -84.56% -1,072.52% -389.10%
Profit (Net Income) Margin
-287.65% -153.70% -141.24% -19.20% -47.07% -341.25% -31.74% -618.78% -83.05% -1,061.45% -385.39%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
91.90% 94.96% 94.22% 80.96% 84.87% 97.38% 92.44% 98.62% 98.21% 98.97% 99.05%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-226.01% -128.20% -122.60% -22.47% -67.15% -396.63% -45.92% -668.12% -94.09% -1,914.30% -240.91%
ROIC Less NNEP Spread (ROIC-NNEP)
-223.13% -124.44% -118.95% -22.00% -66.95% -388.98% -45.34% -653.45% -87.92% -1,897.44% -229.20%
Return on Net Nonoperating Assets (RNNOA)
189.05% 100.38% 93.84% 16.31% 46.86% 284.02% 28.36% 434.12% 56.51% 1,425.77% 143.30%
Return on Equity (ROE)
-36.96% -27.82% -28.77% -6.16% -20.29% -112.61% -17.56% -234.00% -37.58% -488.53% -97.61%
Cash Return on Invested Capital (CROIC)
-268.06% -236.25% -206.41% -148.02% -127.07% -69.94% -90.27% -96.82% -75.41% -261.91% -142.76%
Operating Return on Assets (OROA)
-44.67% -31.95% -33.05% -7.44% -22.56% -118.63% -14.90% -234.08% -35.98% -382.29% -79.29%
Return on Assets (ROA)
-41.05% -30.34% -31.14% -6.03% -19.15% -115.52% -13.77% -230.84% -35.34% -378.34% -78.53%
Return on Common Equity (ROCE)
-36.96% -27.82% -28.77% -6.16% -20.29% -112.61% -17.56% -234.00% -37.58% -488.53% -97.61%
Return on Equity Simple (ROE_SIMPLE)
-58.24% 0.00% -61.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.36 -0.35 -0.33 -0.08 -0.16 -0.44 -0.17 -0.57 -0.21 -0.54 -0.37
NOPAT Margin
-219.11% -113.30% -104.93% -16.60% -45.76% -245.30% -29.96% -439.23% -59.19% -750.76% -272.37%
Net Nonoperating Expense Percent (NNEP)
-2.88% -3.76% -3.65% -0.47% -0.20% -7.65% -0.58% -14.67% -6.17% -16.86% -11.71%
Return On Investment Capital (ROIC_SIMPLE)
- -10.06% -10.66% -2.72% -5.75% -16.78% -6.91% -31.73% -14.19% -58.00% -20.82%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
330.58% 212.82% 202.12% 97.41% 128.35% 360.51% 113.70% 597.30% 145.12% 985.31% 382.47%
R&D to Revenue
82.44% 49.04% 47.78% 26.31% 37.03% 89.92% 29.10% 130.16% 39.43% 187.21% 106.62%
Operating Expenses to Revenue
413.02% 261.86% 249.90% 123.72% 165.38% 450.42% 142.80% 727.47% 184.56% 1,172.52% 489.10%
Earnings before Interest and Taxes (EBIT)
-0.51 -0.51 -0.47 -0.12 -0.20 -0.62 -0.19 -0.82 -0.30 -0.77 -0.53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.47 -0.46 -0.43 -0.07 -0.15 -0.49 -0.15 -0.77 -0.26 -0.73 -0.49
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.39 9.62 14.13 20.63 26.00 22.01 15.67 30.69 35.68 47.21 17.88
Price to Tangible Book Value (P/TBV)
9.39 9.62 14.13 20.63 26.00 22.01 15.67 30.69 35.68 47.21 17.88
Price to Revenue (P/Rev)
49.76 37.21 44.69 48.21 49.95 42.92 24.04 45.15 43.59 39.31 45.68
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
40.04 30.11 41.87 55.17 61.07 90.67 34.15 102.93 141.88 161.20 60.71
Enterprise Value to Revenue (EV/Rev)
45.60 34.49 42.54 46.72 48.83 41.42 23.18 44.11 42.67 38.72 43.85
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.85 -0.81 -0.79 -0.74 -0.70 -0.73 -0.63 -0.66 -0.64 -0.75 -0.63
Leverage Ratio
1.10 1.11 1.12 1.11 1.08 1.29 1.32 1.37 1.33 1.78 1.63
Compound Leverage Factor
1.01 1.05 1.05 0.90 0.92 1.26 1.22 1.35 1.31 1.76 1.61
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
17.84 16.67 10.73 44.44 193.14 -19.00 -28.73 -31.58 -38.16 -59.47 -43.17
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
14.80 12.89 7.49 8.18 16.19 10.21 11.96 7.04 7.61 3.84 6.38
Quick Ratio
14.18 12.54 6.94 7.65 15.31 9.86 11.02 6.46 7.08 3.60 5.77
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-0.61 -0.83 -0.64 -0.36 -0.51 -0.01 -0.25 -0.01 0.59 -0.20 0.20
Operating Cash Flow to CapEx
0.00% -187,281.23% -782,240.00% -179,665.38% -43,865.14% 5,343.93% -582,973.64% -79,222.22% -38,475.34% -323,574.31% -1,134,225.37%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.14 0.20 0.22 0.31 0.41 0.34 0.43 0.37 0.43 0.36 0.20
Accounts Receivable Turnover
0.00 1.14 0.00 1.47 1.66 1.61 1.64 1.51 1.73 2.10 0.92
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
12.25 17.33 21.08 32.05 43.92 48.88 69.87 68.10 90.53 121.58 91.64
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 319.62 0.00 248.88 219.71 227.06 222.18 241.13 211.14 173.65 395.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 319.62 0.00 248.88 219.71 227.06 222.18 241.13 211.14 173.65 395.98
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.83 1.04 0.99 1.08 1.17 0.61 1.07 0.52 0.37 0.27 0.50
Invested Capital Turnover
1.03 1.13 1.17 1.35 1.47 1.62 1.53 1.52 1.59 2.55 0.88
Increase / (Decrease) in Invested Capital
0.25 0.48 0.31 0.28 0.35 -0.43 0.08 -0.56 -0.81 -0.34 -0.57
Enterprise Value (EV)
33 31 41 60 72 55 37 54 52 43 31
Market Capitalization
36 34 44 62 73 57 38 55 54 44 32
Book Value per Share
$0.12 $0.11 $0.09 $0.09 $0.08 $0.08 $0.07 $0.05 $0.04 $0.03 $0.05
Tangible Book Value per Share
$0.12 $0.11 $0.09 $0.09 $0.08 $0.08 $0.07 $0.05 $0.04 $0.03 $0.05
Total Capital
3.85 3.52 3.08 2.99 2.82 2.60 2.43 1.80 1.50 0.93 1.78
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-3.02 -2.48 -2.09 -1.91 -1.65 -1.99 -1.35 -1.27 -1.13 -0.66 -1.28
Capital Expenditures (CapEx)
-0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.62 0.82 0.76 0.89 1.03 0.48 0.96 0.42 0.27 0.18 0.42
Debt-free Net Working Capital (DFNWC)
3.65 3.30 2.85 2.80 2.67 2.48 2.31 1.69 1.40 0.85 1.70
Net Working Capital (NWC)
3.65 3.30 2.85 2.80 2.67 2.48 2.31 1.69 1.40 0.85 1.70
Net Nonoperating Expense (NNE)
0.11 0.13 0.11 0.01 0.00 0.17 0.01 0.23 0.09 0.22 0.15
Net Nonoperating Obligations (NNO)
-3.02 -2.48 -2.09 -1.91 -1.65 -1.99 -1.35 -1.27 -1.13 -0.66 -1.28
Total Depreciation and Amortization (D&A)
0.04 0.04 0.04 0.04 0.04 0.14 0.05 0.05 0.05 0.05 0.04
Debt-free, Cash-free Net Working Capital to Revenue
85.47% 90.45% 77.77% 69.81% 69.86% 36.14% 60.50% 34.15% 22.20% 16.21% 60.38%
Debt-free Net Working Capital to Revenue
501.36% 362.66% 292.53% 218.84% 182.00% 185.46% 146.01% 138.41% 114.30% 75.46% 243.72%
Net Working Capital to Revenue
501.36% 362.66% 292.53% 218.84% 182.00% 185.46% 146.01% 138.41% 114.30% 75.46% 243.72%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.01) ($0.03) ($0.01) $0.00 $0.00 ($0.03) ($0.01) ($0.02) ($0.01) ($0.02) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding
33.51M 33.45M 33.51M 33.52M 33.52M 33.52M 33.65M 33.65M 33.65M 33.65M 34.16M
Adjusted Diluted Earnings per Share
($0.01) ($0.03) ($0.01) $0.00 $0.00 ($0.03) ($0.01) ($0.02) ($0.01) ($0.02) ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding
33.51M 33.45M 33.51M 33.52M 33.52M 33.52M 33.65M 33.65M 33.65M 33.65M 34.16M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
33.51M 33.51M 33.52M 33.52M 33.52M 33.65M 33.65M 33.65M 33.65M 34.65M 34.87M
Normalized Net Operating Profit after Tax (NOPAT)
-0.36 -0.35 -0.33 -0.08 -0.16 -0.44 -0.17 -0.57 -0.21 -0.54 -0.37
Normalized NOPAT Margin
-219.11% -113.30% -104.93% -16.60% -45.76% -245.30% -29.96% -439.23% -59.19% -750.76% -272.37%
Pre Tax Income Margin
-287.65% -153.70% -141.24% -19.20% -47.07% -341.25% -31.74% -618.78% -83.05% -1,061.45% -385.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Research Frontiers (NASDAQ: REFR) continues to look like a small, cash-rich company with very low revenue and ongoing operating losses. Over the last four years, the biggest story is not explosive growth, but a gradual decline in revenue from earlier peaks, persistent negative cash flow from operations, and a business that remains highly dependent on financing and balance-sheet strength.

In Q1 2026, revenue came in at $136.3 thousand, up from $72.1 thousand in Q4 2025 and $129.9 thousand in Q2 2025, but still far below the levels seen in 2024 and much of 2025. The company posted a net loss of $525.4 thousand, which was an improvement from the prior quarter’s $765.6 thousand loss. However, operating expenses remained much larger than revenue, so the business is still not close to profitability.

Cash flow remains a major concern. REFR used $759.9 thousand in operating cash flow during Q1 2026, worse than the $465.9 thousand outflow in Q4 2025. The company did raise $1.375 million from financing activities in the quarter, which helped offset the operating burn and lifted cash and equivalents to $1.28 million at quarter-end from $1.13 million a quarter earlier. That said, the company still depends on external funding to support operations.

The balance sheet shows $3.08 million in total assets against $1.30 million in total liabilities, leaving $1.78 million in equity. That is a reasonably solid equity cushion for a micro-cap company, but much of the asset base is tied up in noncurrent operating assets rather than easily spendable cash. Also, retained earnings remain deeply negative at $(128.1) million, reflecting years of accumulated losses.

Here are the most important takeaways for investors:

  • Cash increased in Q1 2026, rising to $1.28 million from $1.13 million in Q4 2025.
  • Q1 2026 net loss improved quarter over quarter, narrowing to $525.4 thousand from $765.6 thousand.
  • Total liabilities are below total equity, with liabilities of $1.30 million versus equity of $1.78 million.
  • Interest and investment income helped offset losses, contributing $5.0 thousand in Q1 2026.
  • Revenue improved sequentially, but the quarter’s $136.3 thousand in sales is still very small.
  • Share count has drifted upward over time, suggesting mild dilution pressure.
  • Other noncurrent operating assets remain significant, but the statement does not show how quickly those assets can be monetized.
  • Operating cash burn remains substantial, with a $759.9 thousand outflow from operations in Q1 2026.
  • Revenue is well below expense levels, as SG&A alone was $521.4 thousand in Q1 2026.
  • Long-term profitability remains elusive, with consistent quarterly losses across the last four years.

Looking at the broader trend, REFR’s revenue has been volatile and generally lower than the better periods in 2024 and early 2025. Operating losses have continued every quarter in the data provided, and while the company sometimes generates enough financing or investment income to temporarily improve liquidity, the core business still does not appear to be self-funding. For retail investors, that makes the stock more of a speculative turnaround story than a fundamentally proven growth company.

Bottom line: Research Frontiers has enough balance-sheet flexibility to keep operating for now, but the company still needs stronger, more consistent revenue growth and better cost control before investors can view the business as sustainably profitable.

07/21/26 06:29 PM ETAI Generated. May Contain Errors.

Research Frontiers Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Research Frontiers' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Research Frontiers' net income appears to be on a downward trend, with a most recent value of -$2.05 million in 2025, falling from -$4.28 million in 2015. The previous period was -$1.31 million in 2024. Check out Research Frontiers' forecast to explore projected trends and price targets.

Research Frontiers' total operating income in 2025 was -$2.13 million, based on the following breakdown:
  • Total Gross Profit: $1.12 million
  • Total Operating Expenses: $3.25 million

Over the last 10 years, Research Frontiers' total revenue changed from $2.01 million in 2015 to $1.12 million in 2025, a change of -44.1%.

Research Frontiers' total liabilities were at $1.32 million at the end of 2025, a 8.2% decrease from 2024, and a 181.5% increase since 2015.

In the past 10 years, Research Frontiers' cash and equivalents has ranged from $269.96 thousand in 2021 to $6.59 million in 2019, and is currently $664.30 thousand as of their latest financial filing in 2025.

Over the last 10 years, Research Frontiers' book value per share changed from 0.38 in 2015 to 0.03 in 2025, a change of -92.7%.



Financial statements for NASDAQ:REFR last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners